University of Glasgow spinout Chemify has raised $43 million in a Series A funding round. The company provides pharmaceutical, biotechnology, and industrial partners with molecular design services and is the culmination of decades of chemistry research, robotics, AI, and conceptual advancements.
Chemify’s $43 million Series A round was led by Triatomic Capital, with new investors Horizon Ventures, Rocketship Ventures, Possible Ventures, Alix Ventures, Eos, and the UK Government Innovation Accelerators programme participating alongside existing investor BlueYard Capital.
“It has long been our dream to digitise chemistry, and I’m delighted that through this funding, Chemify is building a company that can design, make, and discover complex molecules on demand using digital blueprints faster, more efficiently, and safely than is currently possible,” commented Chemify founder and CEO Lee Cronin. “Our mission is to deliver better molecules for pharmaceutical and industrial partners in a fraction of the time and cost currently required.”